QUOTED. 21 April 2020. Robert Ford.
Despite the ongoing pandemic, Abbott Laboratories reported revenue growth in all four of its main businesses during the first quarter of 2020. See what Abbott’s CEO Robert Ford said about the company’s procedure growth forecast.
“I don’t believe that they’re going to come back at the same speed that they came down, [but] these are important procedures, and I do see them coming back.” – Robert Ford, CEO, Abbott Laboratories
Click here for a free trial of Medtech Insight